Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astera Labs (ALAB) EBT (2023 - 2025)

Historic EBT for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to $66.9 million.

  • Astera Labs' EBT rose 321656.75% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.9 million, marking a year-over-year increase of 28333.21%. This contributed to the annual value of -$81.8 million for FY2024, which is 25636.22% down from last year.
  • Latest data reveals that Astera Labs reported EBT of $66.9 million as of Q3 2025, which was up 321656.75% from $50.7 million recorded in Q2 2025.
  • In the past 5 years, Astera Labs' EBT ranged from a high of $66.9 million in Q3 2025 and a low of -$80.4 million during Q1 2024
  • Over the past 3 years, Astera Labs' median EBT value was $2.0 million (recorded in 2024), while the average stood at $3.1 million.
  • As far as peak fluctuations go, Astera Labs' EBT tumbled by 36398.36% in 2024, and later surged by 321656.75% in 2025.
  • Quarter analysis of 3 years shows Astera Labs' EBT stood at $10.7 million in 2023, then grew by 0.07% to $10.7 million in 2024, then soared by 524.76% to $66.9 million in 2025.
  • Its EBT was $66.9 million in Q3 2025, compared to $50.7 million in Q2 2025 and $21.7 million in Q1 2025.